Filing Details

Accession Number:
0001225208-19-010542
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-26 20:03:54
Reporting Period:
2019-07-25
Accepted Time:
2019-07-26 20:03:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1600739 W.a. Robert Sellers One Edwards Way
Irvine CA 92614
Vp, Corporate Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-25 10,120 $41.94 23,655 No 4 M Direct
Common Stock Acquisiton 2019-07-25 7,297 $35.79 30,952 No 4 M Direct
Common Stock Disposition 2019-07-25 3,000 $213.12 27,952 No 4 S Direct
Common Stock Disposition 2019-07-25 4,625 $209.99 23,327 No 4 S Direct
Common Stock Disposition 2019-07-25 4,800 $212.30 18,527 No 4 S Direct
Common Stock Disposition 2019-07-25 4,992 $211.41 13,535 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Acquire) Disposition 2019-07-25 10,120 $211.57 10,120 $41.94
Common Stock Employee Stock Option (Right to Acquire) Disposition 2019-07-25 7,297 $211.57 7,297 $35.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-05-08 2021-05-07 No 4 M Direct
0 2014-05-14 2020-05-13 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $213.0300 to $213.3300. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $209.7850 to $210.1900. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $211.8100 to $212.5500. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $210.8000 to $211.7800. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.